Annual Wills Eye Hospital Conference Co sponsored by the Wills Eye Alumni Society

Thursday, March 10, 2022, 12:00 PM - Saturday, March 12, 2022, 12:30 PM, Marriott Old City (Philadelphia)


AMA PRA Category 1 Credits™ (15.50 hours)

This is a three day conference designed for comprehensive ophthalmologists, specialists, and allied health personnel.  The conference will review clinical, diagnostic and therapeutic approaches to eye problems related to all ophthalmic sub-specialties.  In a didactic format, nationally recognized physicians will present the current trends in diseases and treatment options for cornea, retina, oculoplastic surgery, and other ophthalmic topics.

1. Apply new concepts in the diagnosis and management of neuro-ophthalmic disorders.
2. Understand the diagnosis and treatment of glaucoma.
3. Improve the quality of personal knowledge for correction of retinal disease.

AMA PRA Statement
Wills Eye Hospital designates this Live Activity for a maximum of 15.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

Wills Eye Hospital CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

In compliance with the standards set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based on scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that planners and speakers have disclosed about all financial relationships they have with commercial entities whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.